Skip to content
by Legal Desire
14 April 2023

Latham & Watkins Advises on Mirum Pharmaceuticals’ Upsized US$275 Million Convertible Senior Notes Offering

Advising firms

Deal team

13 lawyers named
LawyerFirmSeniorityPracticeOffice
Greg Rodgers Lead Latham & Watkins LLP Partner capital markets New York/Los Angeles
Shayne Kennedy Lead Latham & Watkins LLP Partner capital markets Orange County/Bay Area
Arash Aminian Baghai Lead Latham & Watkins LLP Partner capital markets Los Angeles
Ryan Gold Latham & Watkins LLP Associate capital markets Not stated
Eric Hanzich Latham & Watkins LLP Associate capital markets Not stated
Andrew Bentz Latham & Watkins LLP Associate capital markets Not stated
Allison (AJ) Blair Latham & Watkins LLP Associate capital markets Not stated
Christopher Hazuka Latham & Watkins LLP Partner intellectual property Bay Area/San Diego
Robert Yeh Latham & Watkins LLP Associate intellectual property Not stated
Kristina Funahashi Latham & Watkins LLP Associate intellectual property Not stated
Grace Lee Latham & Watkins LLP Partner tax Bay Area
Emmanuel Kassim Latham & Watkins LLP Associate tax Not stated
Elizabeth Richards Latham & Watkins LLP Partner regulatory Washington, D.C.

10 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 275m (US$275 million)
What the figure measures
Issue size
Client
Mirum Pharmaceuticals, Inc.Issuer
Counterparties
initial purchasers (Underwriters)